Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-006832

Chief Financial Officer acquired 3,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2022-02-01 Option exercise +3,875 173,747 D
Derivatives
Ruffo Frank Chief Financial Officer 2022-02-01 Option exercise · Restricted Stock Units −3,875 0 D
Loading xslF345X03/doc4.xml…